Ultra Cold Chain Logistics | Clinical Trial Sample & Product Management
Patient cells that are isolated for development into a therapeutic product must be processed quickly or they lose their integrity and therapeutic value. Cells that cannot be processed immediately must be cryopreserved at -195°C in liquid nitrogen. However,to ensure viability and integrity upon thawing, freezing down to -195°C must be performed at a specific cooling rate, which requires equipment that exceeds the financial resources of most clinical sites.
Download this White Paper to learn more about: